Results from a new study led by researchers at Geisel and presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, showed that stem cell transplantation was beneficial to scleroderma patients who don’t respond to current immunosuppressive therapies.
Post Tagged with: "Scleroderma"
With funding from the Falk Foundation, Mike Whitfield’s lab is mapping which genes interact with each other in the debilitating disease scleroderma. Their discoveries reveal new avenues for treatment.
Ground-breaking discoveries about a rare and debilitating family of diseases has earned Geisel genetics researcher Michael Whitfield, a highly competitive Catalyst Award from the Dr. Ralph and Marian Falk Medical Research Trust.